The underlying mechanisms of Jie-Du-Hua-Yu granule for protecting rat liver failure
The underlying mechanisms of Jie-Du-Hua-Yu granule for protecting rat liver failure
复制标题
解毒化瘀颗粒保护大鼠肝衰竭的机制研究
DOI:
10.2147/dddt.s180969
复制
发表时间:
2019-02
期刊:
影响因子:
--
通讯作者:
Wang Xiufeng
中科院分区:
文献类型:
--
作者:
Qiu Hua;Mao Dewen;Tang Nong;Long Fuli;Zhang Rongzhen;Wang Minggang;Shi Qinglan;Li Jiahuan;Jiang Qin;Chen Yueqiao;Wang Xiufeng
Objectives Jie-Du-Hua-Yu (JDHY) granule is a combination of six traditional Chinese medicines with known therapeutic effect in treating acute liver failure (ALF). The aim of this study was to investigate the amelioration efficacy of JDHY in lipopolysaccharide/D-galactosamine (LPS/D-GalN)-induced ALF in rat and explore the possible molecular mechanism underlying the therapeutic efficacy. Materials and methods The efficacy of JDHY was determined by assessing hepatic pathology and function in LPS and D-GalN challenged Wistar rat. We also evaluated the effect of JDHY on LPS-induced Kupffer cells by measuring inflammatory cytokines and determining the phenotypic function. By means of bioinformatics analysis of liver tissue and validation in Kupffer cells, we identified possible pathways involved in the pharmacologic action of mechanism of JDHY. Results JDHY could attenuate LPS-induced liver injury in rat by inhibiting apoptosis and increasing hepatic activity. In vitro study showed that JDHY could decrease the production of proinflammatory cytokines (tumor necrosis factor-α, IL6, and interferon-γ), increase anti-inflammatory cytokines (IL10, IL13), and promote cell survival and proliferation, possibly due to inhibition of IκB/nuclear factor-κB (NF-κB) signaling pathway and expression of CD14 and CXCL2, which was consistent with the findings from bioinformatics analysis. Conclusion Our results revealed that JDHY protected against LPS-induced liver damage both in vitro and in vivo, by inhibiting the NF-κB-mediated inflammatory pathway, indicating its potential function to treat liver diseases.
登录
查看更多内容
DOI:
10.1155/2017/9819350
发表时间:
2017
期刊:
Evidence-based complementary and alternative medicine : eCAM
影响因子:
--
作者:
Wang M;Shi Q;Zhang R;Qiu H;Mao D;Long F
通讯作者:
Long F
影响因子:
13.5
作者:
Gustot, Thierry;Fernandez, Javier;Arroyo, Vicente
通讯作者:
Arroyo, Vicente
影响因子:
6.7
作者:
Li, G;Qi, XP;Li, JS
通讯作者:
Li, JS
影响因子:
3.1
作者:
Zhang Rong-Zhen;Qiu Hua;Wang Na;Long Fu-Li;Mao De-Wen
通讯作者:
Mao De-Wen
DOI:
--
发表时间:
2009
期刊:
--
影响因子:
--
作者:
Long Fu-li
通讯作者:
Long Fu-li